Herpes simplex virus (HSV) has a long and confusing history. More than 2500 years ago, Hippocrates first used the word “herpes,” derived from the Greek word “to creep,” to describe how the lesions of this contagious ulcerative disease seemed to creep or crawl along the skin (1). Galen first noted that recurrences develop at the same anatomic site. However, overtime, the word herpes was used to describe many skin conditions from lupus to zoster. The definition of herpes (particularly oral lesions) became more rigorous in the 17th century. In the 1830s, recurrent genital herpes was described and 60 years later was identified as a “vocational disease”—a sexually transmitted infection (STI). The virus itself was not identified until the 1950s. In 1971, it was proposed that two different types of HSV caused infection. HSV-1 commonly causes labial or pharyngeal infection, and transmission is primary by nongenital contact. HSV-2 typically affects the genital area and is transmitted by intimate sexual contact. However, both viruses are capable of causing either genital or oral-pharyngeal infections that appear identical on examination. In the United States, HSV infection is one of the most common STIs and is the leading cause of genital ulcers.
- Human Immunodeficiency Virus
- Herpes Simplex Virus Type
- Sexually Transmitted Infection
- Genital Herpes
- Sexually Transmitted Disease
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Tax calculation will be finalised at checkout
Purchases are for personal use onlyLearn about institutional subscriptions
Unable to display preview. Download preview PDF.
Roizman B, Whitley RJ. The nine ages of herpes simplex virus. Herpes 2001; 8:23–27.
Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296(8):964–973.
Yeung-Yue KA, Brentjens MH, Lee PC, Tyring SK. Herpes simplexviruses 1 and 2. Dermatol Clin 2002; 20:249–266.
Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116:197–202.
Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11–20.
National Institute of Allergy and Infectious Diseases. Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. Washington, DC: National Institutes of Health, Department of Health Services; 2001. Available from: http://www.niaid.nih.gov/dmid/stds/condomreport.pdf. Accessed June 4, 2005.
World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva: World Health Organization; 2001. Available from: http://www.who.int/emc-documents/STIs/whocdscsredc200110c.html Accessed July 10, 2005.
Schacker T. The role of HSV in the transmission and progression of HIV. Herpes 2001; 8: 46–49.
Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998; 280:61–66.
Mole L, Ripich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997; 176:766–770.
Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45–52.
Wald A. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes 2004; 11:130A–137A.
Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285:3100–3106.
Cherpes TL, Meyn LA, Krohn MA, Hillier SL. Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis 2003; 30:405–410.
Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341:1432–1438.
Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000; 181:1454–1457.
Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342:844–850.
Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 1997; 99:1092–1097.
Bryson Y, Dillon M, Bernstein DI, Radolf J, Zakowski P, Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 1993; 167:942–946.
Koelle DM, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 1992; 116: 433–437.
Scoular A. Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sex Transm Infect 2002; 78:160–165.
Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic firstepisode infection. Ann Intern Med 1994; 121:847–854.
Kimberlin DW, Rouse DJ. Clinical practice. Genital herpes. N Engl J Med 2004; 350:1970–1977.
Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983; 98:958–972.
Patel R, Boselli F, Cairo I, Barnett G, Price M, Wulf HC. Patients’ perspectives on the burden of recurrent genital herpes. Int J STD AIDS 2001; 12:640–645.
Sweet RL, Gibbs RS. Herpes simplex virus infection. In: Infectious Diseases of the Female Genital Tract, 4th Ed. Philadelphia, PA: Lippincott, Williams &Wilkins, 2002; pp. 101–117.
Kessler HA, Baker DA, Brown ZA, Leone PA. Herpesvirus management: special considerations for the female patient. A monograph based on a symposium held May 6, 2002. New York, NY: New World Health; 2002.
Ebel C, Wald A. Managing Herpes: How to Live and Love with a Chronic STD, 3rd Ed. Research Park Triangle, NC: American Social Health Association; 2002.
Schacker T. The role of HSV in the transmission and progression of HIV. Herpes 2001; 8(2):46–49.
Kaufman RH, Gardner HL, Rawls WE, Dixon RE, Young RL. Clinical features of herpes genitalis. Cancer Res 1973; 33:1446–1451.
Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999; 131:14–20.
Fleming DT, Leone P, Esposito D. Herpes virus infection and genital symptoms in primary care patients. Sex Transm Inf 2006; 33(7):416–421.
Waggoner-Fountain LA, Grossman LB. Herpes simplex virus. Pediatr Rev 2004; 25:86–93.
Crist GA, Langer JM, Woods GL, Procter M, Hillyard DR. Evaluation of the ELVIS plate method for the detection and typing of herpes simplex virus in clinical specimens. Diagn Microbiol Infect Dis 2004; 49:173–177.
Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002; 51:1–78.
Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. JAMA 1998; 280:887–892.
Tyring SK, Baker D, Snowden W. Valacyclovir for herpes simplex virus infection: longterm safety and sustained efficacy after 20 years experience with acyclovir. J Infect Dis 2002; 186:S40–46.
Parks DG, Greenway FL, Pack AT. Prevention of recurrent herpes simplex type II infection with lithium carbonate. Med Sci Research 1988; 16:971–972.
Alexander L, Naisbett B. Patient and physician partnerships in managing genital herpes. J Infect Dis 2002; 186:S57–S65.
Brown ZA, Gardella C, Wald A, Morrow RA, Corey L. Genital herpes complicating pregnancy. Obstet Gynecol 2005; 106(4):845–856.
Eskild A, Jeansson S, Stray-Pedersen B, Jenum PA. Herpes simplex virus type-2 infection in pregnancy: no risk of fetal death: results from a nested case-control study within 35,940 women. BJOG 2002; 109:1030–1035.
Brown Z. Preventing herpes simplex virus transmission to the neonate. Herpes 2004; 11: 175A–186A.
Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev 2004; 17(1): 1–13.
Smith JR, Cowan FM, Munday P. The management of herpes simplex virus infection in pregnancy. Br J Obstet Gynaecol 1998; 105:255–260.
Watts DH, Brown ZA, Money D, et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003; 188:836–843.
Thung SF, Grobman WA. The cost-effectiveness of routine antenatal screening for maternal herpes simplex virus-1 and-2 antibodies. Am J Obstet Gynecol 2005; 192:483–488.
Baker D, Brown Z, Hollier LM, et al. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am J Obstet Gynecol 2004; 191:2074–2084.
American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of herpes in pregnancy. Number 8 October 1999. Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 2000; 68:165–173.
Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 2003; 102: 1396–1403.
Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652–1661.
Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143(10):707–713.
Rana RK, Pimenta JM, Rosenberg DM, et al. Sexual behaviour and condom use among individuals with a history of symptomatic genital herpes. Sex Transm Inf 2006; 82(1):69–74.
Editors and Affiliations
© 2006 Humana Press Inc.,Totowa NJ
About this chapter
Cite this chapter
Parks, G. (2006). Genital Herpes. In: Nelson, A.L., Woodward, J., Wysocki, S. (eds) Sexually Transmitted Diseases. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-040-9_3
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-570-5
Online ISBN: 978-1-59745-040-9